特发性炎性肌病中多种肌炎特异性自身抗体的检测:单中心经验与系统综述
该研究在145例特发性炎性肌病(IIM)患者和240例对照中评估多种肌炎特异性自身抗体(MSA)的检出情况,并系统检索截至2019年2月的文献。单中心显示多种MSA检出率为3.4-8.3%,取决于检测方法,但三种方法均未发现完全一致病例;文献汇总133例,多数表型仅匹配一种MSA。
要点
- 多种MSA在IIM患者中并非罕见,检出率因检测方法而异(3.4-8.3%)。
- 商业多重免疫检测法的特异性问题可能部分解释其高于免疫沉淀法的检出率。
- 真正的多种MSA阳性患者可能存在,但很可能罕见。
核心结论
- IIM患者中多种MSA的检出比通常认为的更常见,但真正的多种MSA阳性可能罕见。
研究设计与样本
- 单中心回顾性分析145例IIM患者和240例对照,使用两种线性免疫分析和一种斑点免疫分析检测多种MSA。
- 系统检索PubMed和Embase截至2019年2月发表的相关文献。
主要发现
- 单中心多种MSA检出率为3.4-8.3%,取决于检测方法,但三种方法间无完全一致病例。
- 101例仅用单一检测方法检出所有MSA:40例基于免疫沉淀法,61例其他检测类型。
- 多数多种MSA患者的表型与一种MSA的预期表现匹配,少数与两种MSA均匹配。
临床怎么用
- 临床解读多种MSA阳性结果时需考虑检测方法,商业多重免疫检测可能因特异性问题出现假阳性。
局限性
- 单中心经验,样本量有限;文献汇总病例存在异质性且部分检测方法不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Myositis-specific autoantibodies (MSAs) are thought to be mutually exclusive in patients with idiopathic inflammatory myopathies (IIM) based on studies with immunoprecipitation-based (IP) detection methods. Recently, detection of multiple MSAs in unique patients is increasingly reported, but the extent of this phenomenon remains unclear. METHODS: At our centre, we reviewed results from two line immunoassays and one dot immunoassay in 145 IIM patients and 240 controls for the presence of multiple MSAs. Pubmed and Embase were systematically searched for articles mentioning detection of multiple MSAs in IIM patients, published until February 2019. We assessed the frequency, detection method, the precise combinations and clinical phenotypes of participants with multiple MSAs. RESULTS: At our centre, detection of multiple MSAs occurred in 3.4-8.3% of patients with IIM, depending on the assay. However, no cases with full concordance across all three assays were identified. Forty-four articles reported detection of multiple MSAs, representing a total of 133 cases, including four patients with a connective tissue disease other than IIM and two healthy controls. In 101 cases all MSAs were detected using only one detection method: 40 cases with IP-based methods (most frequently used technique) and 61 cases with other assay types. In most cases the phenotype of patients with multiple MSAs matched the predicted presentation associated with one MSA and in few cases the phenotype matched with both MSAs. CONCLUSION: Detection of multiple MSAs in unique IIM patients is less rare than commonly accepted. Specificity issues of the commercially available multiplex immunoassays may, at least partly, explain the higher frequency compared to IP-based methods. 'True multiple MSA-positive' patients may exist, though they are most likely rare.
引用
- Van Horebeek N, Vulsteke JB, Bossuyt X, et al. Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review. Semin Arthritis Rheum. 2021. PMID: 33831755. doi:10.1016/j.semarthrit.2021.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。